Cofactor Genomics In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More News items for the week of Dec. 12, 2022. Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors. Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow. Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds Premium The firm highlighted a new study exploring immune-related gene expression in ovarian cancer and gave an update on its lead diagnostic candidate for head and neck tumors. Cofactor Genomics, UCSD Partner on Metastatic Head, Neck Cancer Study The company will work with university researchers to evaluate its predictive immune modeling technology in personalizing the use of immune checkpoint inhibitors. Jan 4, 2019 Cofactor Genomics Hopes to Drive RNA Dx Progress With Kit Dissemination Premium Dec 4, 2018 Cofactor Genomics Inks Pilot Study Deal for Immune Profiling Kit Evaluation Mar 20, 2018 Cofactor Genomics, NCI Partner to Validate RNA-Based Immune Profiling Assay Feb 16, 2018 Cofactor Pushes RNA-Based Dx Goals With New Immuno-Oncology Assay Premium Sep 18, 2017 Cofactor Genomics Raises $18M in Series A Round Mar 21, 2017 Cofactor Genomics Launches First RNA-Seq Clinical Assay Premium Dec 1, 2016 Cofactor Genomics, FLX Bio Partner on Immuno-Oncology Analysis Platform Mar 1, 2016 Systems Imagination, Cofactor Genomics Ink Drug Development Services Deal Feb 3, 2016 Cofactor Genomics Acquires Narus Biotechnologies Jul 21, 2015 Cofactor Genomics Awarded $1.5M NIH Grant for Circular RNA Enrichment Tech Feb 19, 2015 Cofactor Genomics Named Agilent CSP for NGS Target Enrichment Sep 19, 2014 Cofactor Genomics Wins $300K Contract for Epigenetics Study of Cardiovascular Disease Nov 19, 2013 Cofactor Genomics Doubles Sequencing Capacity and Launches RNA-seq Dx as it Moves into New Digs Premium Oct 8, 2013 Sage Labs Partners with Cofactor Genomics on RNA Sequencing Services Mar 5, 2013 Cofactor Genomics Set to Offer Services in Exchange for Sequencer Trade-Ins Premium Mar 6, 2012 Paired Ends: Don Henricksen, Robert Nussbaum, Hesaam Esfandyarpour, Ron Davis, George Church, and More Premium Jan 13, 2012 Cofactor Taps Intrepid to Provide Visualization Capabilities for Cow Exome Capture Offering Premium Jan 10, 2012 Cofactor, Intrepid Integrate Cow Genome Analysis Tools Dec 6, 2011 New Products: Cofactor Genomics' Bovine Exome Capture Kit; GIS's Opera; Bowtie Updated Premium Nov 1, 2011 Cofactor Genomics Collaborates with Kentucky Network on Sequencing Data Load More Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.